Chemoprevention of Breast Cancer: A Model for Change
- 1 January 2002
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (1), 1-3
- https://doi.org/10.1200/jco.2002.20.1.1
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: A Cost-Effectiveness AnalysisJournal of Clinical Oncology, 2002
- Patient Reluctance Toward Tamoxifen Use for Breast Cancer Primary PreventionAnnals of Surgical Oncology, 2001
- UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 yearsThe Lancet, 2000
- Health-Related Quality of Life and Tamoxifen in Breast Cancer Prevention: A Report From the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJournal of Clinical Oncology, 1999
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal WomenJAMA, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomataEuropean Journal of Cancer (1965), 1976